These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. H3F3A G34 mutation DNA sequencing and G34W immunohistochemistry analysis in 366 cases of giant cell tumors of bone and other bone tumors. Gong L, Bui MM, Zhang W, Sun X, Zhang M, Yi D. Histol Histopathol; 2021 Jan; 36(1):61-68. PubMed ID: 33021329 [Abstract] [Full Text] [Related]
5. H3F3A-mutated giant cell tumour of bone without giant cells-clinical presentation, radiology and histology of three cases. Leinauer B, Wolf E, Werner M, Baumhoer D, Breining T, Luebke AM, Maas R, Schultheiß M, von Baer A, Sufi-Siavach A, Moritz C, Geißler S, Mellert K, Möller P, Barth TFE, Jundt G. Histopathology; 2021 Nov; 79(5):720-730. PubMed ID: 33991114 [Abstract] [Full Text] [Related]
7. Anti-Histone H3.3 G34W antibody is a sensitive and highly specific immunohistochemistry marker for the diagnosis of Giant cell tumor of bone. A validation based on analysis of 198 cases from a single centre in India. Kamble A, Hui M, Rao KN, Narayanan R, Reddy BR, Uppin SG, Chandrasekhar P. Indian J Pathol Microbiol; 2022 Nov; 65(3):617-629. PubMed ID: 35900490 [Abstract] [Full Text] [Related]
10. H3F3A (Histone 3.3) G34W Immunohistochemistry: A Reliable Marker Defining Benign and Malignant Giant Cell Tumor of Bone. Amary F, Berisha F, Ye H, Gupta M, Gutteridge A, Baumhoer D, Gibbons R, Tirabosco R, O'Donnell P, Flanagan AM. Am J Surg Pathol; 2017 Aug; 41(8):1059-1068. PubMed ID: 28505000 [Abstract] [Full Text] [Related]
11. Diagnostic Utility of Genetic and Immunohistochemical H3-3A Mutation Analysis in Giant Cell Tumour of Bone. Wągrodzki M, Tysarowski A, Seliga K, Wojnowska A, Stepaniuk M, Castañeda Wysocka P, Makuła D, Pieńkowski A, Szostakowski B, Zub R, Rutkowski P. Int J Mol Sci; 2022 Jan 16; 23(2):. PubMed ID: 35055156 [Abstract] [Full Text] [Related]
16. [The study of the value of H3F3A G34W immunohistochemical staining in the diagnosis of giant cell tumor of bone]. Bai YQ, Yang TT, Zhang HZ. Zhonghua Bing Li Xue Za Zhi; 2019 Jul 08; 48(7):531-536. PubMed ID: 31288308 [Abstract] [Full Text] [Related]
18. Knock-down of oncohistone H3F3A-G34W counteracts the neoplastic phenotype of giant cell tumor of bone derived stromal cells. Fellenberg J, Sähr H, Mancarella D, Plass C, Lindroth AM, Westhauser F, Lehner B, Ewerbeck V. Cancer Lett; 2019 Apr 28; 448():61-69. PubMed ID: 30742944 [Abstract] [Full Text] [Related]
19. Mutation Analysis of H3F3A and H3F3B as a Diagnostic Tool for Giant Cell Tumor of Bone and Chondroblastoma. Cleven AH, Höcker S, Briaire-de Bruijn I, Szuhai K, Cleton-Jansen AM, Bovée JV. Am J Surg Pathol; 2015 Nov 28; 39(11):1576-83. PubMed ID: 26457357 [Abstract] [Full Text] [Related]
20. H3F3A mutation as a marker of malignant giant cell tumor of the bone: A case report and review of literature. Ratnagiri R, Uppin S. J Cancer Res Ther; 2023 Nov 28; 19(3):832-834. PubMed ID: 37470622 [Abstract] [Full Text] [Related] Page: [Next] [New Search]